申请人:Boehringer Ingelheim GmbH
公开号:US04021551A1
公开(公告)日:1977-05-03
Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen or methyl, R.sub.2 and R.sub.3, together with each other and the nitrogen atom to which they are attached, form a saturated or unsaturated heterocyclic ring system which may optionally contain one or more additional heteroatoms, and A is lower alkylene or aryl-lower alkylene, and nontoxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as inducers of the formation of interferon.
化合物的式为##STR1##其中R.sub.1是氢或甲基,R.sub.2和R.sub.3与彼此和它们连接的氮原子一起形成饱和或不饱和的杂环环系统,该环系统可以选择性地包含一个或多个额外的杂原子,A是较低的烷基或芳基-较低的烷基,以及其无毒、药理学上可接受的酸盐;这些化合物及其盐可用作诱导干扰素形成的药物。